METROPOLITAN LIFE INSURANCE CO/NY - SYNDAX PHARMACEUTICALS INC ownership

SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 139 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.5%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of SYNDAX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$98,770
+20.1%
4,150
+9.0%
0.00%0.0%
Q4 2023$82,269
+48.8%
3,8070.0%0.00%
+33.3%
Q3 2023$55,278
-26.7%
3,807
+5.7%
0.00%
-25.0%
Q2 2023$75,390
+9.7%
3,602
+10.7%
0.00%0.0%
Q1 2023$68,724
-17.9%
3,254
-1.1%
0.00%0.0%
Q4 2022$83,756
+13.1%
3,291
+6.8%
0.00%0.0%
Q3 2022$74,036
+24.9%
3,0810.0%0.00%
+33.3%
Q2 2022$59,278
+10.7%
3,0810.0%0.00%
+50.0%
Q1 2022$53,548
-81.3%
3,081
-76.4%
0.00%
-50.0%
Q4 2021$285,818
+14.5%
13,0570.0%0.00%0.0%
Q3 2021$249,519
+11.3%
13,0570.0%0.00%
+33.3%
Q2 2021$224,189
+26.4%
13,057
+64.7%
0.00%0.0%
Q1 2021$177,315
+0.5%
7,9300.0%0.00%0.0%
Q4 2020$176,363
+50.7%
7,9300.0%0.00%
+50.0%
Q3 2020$117,047
-0.4%
7,9300.0%0.00%0.0%
Q2 2020$117,523
+35.1%
7,9300.0%0.00%0.0%
Q1 2020$86,9927,9300.00%
Other shareholders
SYNDAX PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,025,000$19,588,0003.91%
Ghost Tree Capital, LLC 575,000$10,988,0003.21%
Avidity Partners Management LP 4,823,400$92,175,0002.04%
BVF INC/IL 2,486,429$47,516,0001.85%
FRAZIER MANAGEMENT LLC 1,188,135$22,705,0001.82%
Nantahala Capital Management 2,657,159$50,778,0001.60%
Boxer Capital, LLC 2,287,782$43,720,0001.53%
ACUTA CAPITAL PARTNERS, LLC 206,126$3,939,0001.39%
SPHERA FUNDS MANAGEMENT LTD. 750,603$14,344,0001.20%
PFM Health Sciences, LP 1,856,738$35,482,0001.04%
View complete list of SYNDAX PHARMACEUTICALS INC shareholders